Management of Mast Cell Activation Syndrome

Alternative First-Line Medications

Oral cromolyn sodium can be used as an alternative first-line therapy, particularly effective for gastrointestinal symptoms such as bloating, diarrhea, and abdominal cramps, with benefits extending to neuropsychiatric manifestations, according to the American Academy of Allergy, Asthma, and Immunology 1.
Omalizumab (anti-IgE therapy) has shown efficacy in preventing anaphylactic episodes in some MCAS patients who cannot tolerate conventional therapies, as recommended by the American Academy of Allergy, Asthma, and Immunology 1.
Zileuton (5-lipoxygenase inhibitor) may be considered if the patient has elevated urinary LTE4 levels, particularly for respiratory symptoms, as suggested by the American Academy of Allergy, Asthma, and Immunology 1.

Supine positioning should be implemented immediately during reactions, with patients trained to assume this position as soon as symptoms begin, using a bedpan for diarrhea and an emesis basin when needed, as recommended by the American Academy of Allergy, Asthma, and Immunology 1.
Albuterol via nebulizer or metered-dose inhaler can be used to treat bronchospasm symptoms if tolerated, according to the American Academy of Allergy, Asthma, and Immunology 1.

Steroid taper/burst may be useful for refractory symptoms at an initial oral dosage of 0.5 mg/kg/day, followed by a slow taper over 1-3 months, as recommended by the American Academy of Allergy, Asthma, and Immunology 1.
For patients requiring procedures, consider administering 50 mg prednisone at 13 hours, 7 hours, and 1 hour before radiologic or invasive procedures when mast cell activation has been problematic, as suggested by the American Academy of Allergy, Asthma, and Immunology 1.

Cytoreductive therapy with interferon-alfa can be considered for severe cases refractory to conventional therapy, as recommended by the National Comprehensive Cancer Network 2, 3.
Tyrosine kinase inhibitors such as midostaurin (100 mg twice daily with food) may be considered in severe cases, though careful monitoring for toxicity is required, according to the National Comprehensive Cancer Network 4.

Benzodiazepines can be used as anxiolytic agents to help prevent mast cell activation events, as recommended by the National Comprehensive Cancer Network 2, 5.
Propofol for anesthetic induction or sevoflurane/isoflurane for inhalational anesthesia are considered safer options for MCAS patients requiring procedures, according to the National Comprehensive Cancer Network 2.
Fentanyl or remifentanil are preferred analgesics for MCAS patients, as recommended by the National Comprehensive Cancer Network 2.
Avoid muscle relaxants such as atracurium and mivacurium; rocuronium and vecuronium may be safer alternatives, according to the National Comprehensive Cancer Network 6.

Careful trigger identification and avoidance is crucial for management, as recommended by the American Academy of Allergy, Asthma, and Immunology 1.
Medication trials should be conducted in a controlled setting with emergency equipment readily available, according to the American Academy of Allergy, Asthma, and Immunology 7.
Serum tryptase levels should be checked within 30-120 minutes of symptom onset during reactions to confirm mast cell activation, as recommended by the National Comprehensive Cancer Network 2.
Full allergic workup including skin testing and specific IgE detection should be conducted to identify potential IgE-mediated hypersensitivities, according to the National Comprehensive Cancer Network 2.

Patients with MCAS who are also on beta-adrenergic blocking agents may require more intensive and prolonged treatment for anaphylactoid reactions, as recommended by the American Academy of Allergy, Asthma, and Immunology 7.
Cognitive decline has been reported with H1 blockers that have anticholinergic effects, especially in elderly populations, according to the American Academy of Allergy, Asthma, and Immunology 8.